Stuart G. Turville is an immunologist based in Sydney, working at St. Vincent's Clinical School, Sydney, NSW 2010, Australia. Immunology is all about how the body’s defence system works, and what happens when it doesn’t.
In day-to-day care, Stuart looks after people dealing with serious and ongoing immune-related health issues. That can include infections like HIV/AIDS, and illnesses such as COVID-19. Some people also need help after the first infection has passed, including long-term effects often described as Long Haul COVID.
Stuart also supports patients with blood and immune cancers. This includes conditions like chronic B-cell leukaemia (CBCL) and chronic lymphocytic leukaemia (CLL). You may also see related diagnoses such as follicular lymphoma, small lymphocytic lymphoma (SLL), and Waldenstrom macroglobulinaemia. These illnesses can affect both immunity and how the body copes over time, so care needs to be steady and well planned.
Respiratory infections are another key part of the picture. Pneumonia can range from mild to very serious, and immune status can change how quickly people recover. At times, severe viral illnesses can also be part of the work, including past outbreaks like severe acute respiratory syndrome (SARS). The immune system’s role matters a lot in these cases, from early illness through recovery.
Over time, immunology care often involves watching symptoms, managing risk, and adjusting treatment plans as the situation changes. In many cases, that means working with other teams so patients get the right mix of care. Stuart’s role is to bring a clear immune-focused view to help guide decisions and explain what the body is doing.
Stuart works within a clinical teaching setting, so the environment is focused on practical patient care. It also means staying up to date with what’s being learned in immunology and infectious disease, so that care doesn’t fall behind.
At the moment, specific clinical trial involvement isn’t listed here. But the work sits in an area where new evidence matters, especially for infections and immune-related cancers. Patients typically need care that balances today’s symptoms with what the immune system is likely to do next.